HCC827 cells were stained with anti-E-cadherin followed by a secondary antibody and mounted with DAPI Fluoromount-G® (SB Cat. No. 0100-20). Image from Narita M, Shimura E, Nagasawa A, Aiuchi T, Suda Y, Hamada Y, et al. Chronic treatment of non-small-cell lung cancer cells with gefitinib leads to an epigenetic loss of epithelial properties associated with reductions in microRNA-155 and -200c. PLoS One. 2017;12(2):e0172115. Figure 4(e)
HCC827 cells were stained with anti-E-cadherin followed by a secondary antibody and mounted with DAPI Fluoromount-G® (SB Cat. No. 0100-20). Image from Narita M, Shimura E, Nagasawa A, Aiuchi T, Suda Y, Hamada Y, et al. Chronic treatment of non-small-cell lung cancer cells with gefitinib leads to an epigenetic loss of epithelial properties associated with reductions in microRNA-155 and -200c. PLoS One. 2017;12(2):e0172115. Figure 4(e)
DAPI Fluoromount-G(r)
0100-20
Product group Technique Specific Products
Overview
- SupplierSouthernBiotech
- Product NameDAPI Fluoromount-G(r)
- Delivery Days Customer7
- ApplicationsImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin, Other Application
- CertificationResearch Use Only
- Scientific DescriptionDAPI Fluoromount-G® is a water-soluble, 4,6-diamidino-2-phenylindole (DAPI) containing compound recommended for slides mounted after a staining procedure having an aqueous final step. When bound to DNA, DAPI fluoresces and is typically used as a nuclear/chromosomal counterstain. Since DAPI Fluoromount-G® is water-soluble, the coverslip may be removed by submerging the slide in a PBS solution until the coverslip is loosened. This mounting medium also provides a semi-permanent seal for storage of slide preparations.
- Storage InstructionRT
- UNSPSC41102904